Condensed Consolidating Financial Information (Condensed Consolidating Statements Of Cash Flows) (Detail) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Mar. 31, 2015 | Mar. 31, 2014 |
Condensed Financial Statements, Captions [Line Items] | | |
Net income (loss) | $18,940 | $25,485 |
Adjustments to reconcile net income to cash provided by (used for) operating activities: | | |
Equity in earnings of subsidiaries | 0 | 0 |
Depreciation and amortization | 19,123 | 13,864 |
Share-based compensation expense | 2,597 | 2,642 |
Provision for losses on accounts and notes receivable | 220 | 54 |
Deferred income tax expense (benefit) | 510 | -822 |
Changes in operating assets and liabilities: | | |
Accounts and notes receivable | 27,356 | 29,828 |
Merchandise inventories | -3,888 | 3,707 |
Accounts payable | 88,944 | 15,815 |
Net change in other assets and liabilities | 13,580 | 3,921 |
Other, net | 1,321 | -1,292 |
Cash provided by operating activities | 168,703 | 93,202 |
Investing activities: | | |
Additions to property and equipment | -7,619 | -7,299 |
Payments to Acquire Software | 3,947 | 6,930 |
Additions to property and equipment | 0 | 1,937 |
Proceeds from the sale of property and equipment | 50 | 105 |
Cash used for investing activities | -11,516 | -12,187 |
Financing activities: | | |
Change in bank overdraft | 1,179 | 20,578 |
Change in intercompany advances | 0 | 0 |
Repayment of revolving credit facility | -33,700 | 0 |
Cash dividends paid | -15,934 | -15,785 |
Repurchases of common stock | 0 | -5,000 |
Excess tax benefits related to share-based compensation | 240 | 346 |
Proceeds from exercise of stock options | 125 | 937 |
Other, net | -2,324 | -1,868 |
Cash used for financing activities | -50,414 | -792 |
Effect of exchange rate changes on cash and cash equivalents | -4,489 | 245 |
Net increase in cash and cash equivalents | 102,284 | 80,468 |
Cash and cash equivalents at beginning of period | 56,772 | 101,905 |
Cash and cash equivalents at end of period | 159,056 | 182,373 |
Owens & Minor, Inc. | | |
Condensed Financial Statements, Captions [Line Items] | | |
Net income (loss) | 18,940 | 25,485 |
Adjustments to reconcile net income to cash provided by (used for) operating activities: | | |
Equity in earnings of subsidiaries | -24,153 | -27,054 |
Depreciation and amortization | 0 | 2 |
Share-based compensation expense | 0 | 0 |
Provision for losses on accounts and notes receivable | 0 | 0 |
Deferred income tax expense (benefit) | 0 | 0 |
Changes in operating assets and liabilities: | | |
Accounts and notes receivable | 0 | 0 |
Merchandise inventories | 0 | 0 |
Accounts payable | 0 | 0 |
Net change in other assets and liabilities | 541 | 3,138 |
Other, net | 209 | -388 |
Cash provided by operating activities | -4,463 | 1,183 |
Investing activities: | | |
Additions to property and equipment | 0 | 0 |
Payments to Acquire Software | 0 | 0 |
Additions to property and equipment | | 0 |
Proceeds from the sale of property and equipment | 0 | 0 |
Cash used for investing activities | 0 | 0 |
Financing activities: | | |
Change in bank overdraft | 0 | 0 |
Change in intercompany advances | 114,499 | 78,263 |
Repayment of revolving credit facility | 0 | |
Cash dividends paid | -15,934 | -15,785 |
Repurchases of common stock | | -5,000 |
Excess tax benefits related to share-based compensation | 240 | 346 |
Proceeds from exercise of stock options | 125 | 937 |
Other, net | -867 | -1,035 |
Cash used for financing activities | 98,063 | 57,726 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 93,600 | 58,909 |
Cash and cash equivalents at beginning of period | 22,013 | 74,391 |
Cash and cash equivalents at end of period | 115,613 | 133,300 |
Guarantor Subsidiaries | | |
Condensed Financial Statements, Captions [Line Items] | | |
Net income (loss) | 28,396 | 30,158 |
Adjustments to reconcile net income to cash provided by (used for) operating activities: | | |
Equity in earnings of subsidiaries | 0 | 0 |
Depreciation and amortization | 9,105 | 8,952 |
Share-based compensation expense | 2,597 | 2,570 |
Provision for losses on accounts and notes receivable | -36 | 96 |
Deferred income tax expense (benefit) | -373 | -588 |
Changes in operating assets and liabilities: | | |
Accounts and notes receivable | 26,519 | 26,879 |
Merchandise inventories | -2,348 | 7,563 |
Accounts payable | 92,359 | 23,375 |
Net change in other assets and liabilities | 16,418 | 12,734 |
Other, net | 636 | -745 |
Cash provided by operating activities | 173,273 | 110,994 |
Investing activities: | | |
Additions to property and equipment | -6,552 | -4,036 |
Payments to Acquire Software | 1,457 | 6,139 |
Additions to property and equipment | | 1,937 |
Proceeds from the sale of property and equipment | 50 | 11 |
Cash used for investing activities | -7,959 | -8,227 |
Financing activities: | | |
Change in bank overdraft | 0 | 0 |
Change in intercompany advances | -124,681 | -78,631 |
Repayment of revolving credit facility | -33,700 | |
Cash dividends paid | 0 | 0 |
Repurchases of common stock | | 0 |
Excess tax benefits related to share-based compensation | 0 | 0 |
Proceeds from exercise of stock options | 0 | 0 |
Other, net | -710 | -579 |
Cash used for financing activities | -159,091 | -79,210 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 6,223 | 23,557 |
Cash and cash equivalents at beginning of period | 3,912 | 2,012 |
Cash and cash equivalents at end of period | 10,135 | 25,569 |
Non-guarantor Subsidiaries | | |
Condensed Financial Statements, Captions [Line Items] | | |
Net income (loss) | -4,629 | -3,124 |
Adjustments to reconcile net income to cash provided by (used for) operating activities: | | |
Equity in earnings of subsidiaries | 0 | 0 |
Depreciation and amortization | 10,018 | 4,910 |
Share-based compensation expense | 0 | 72 |
Provision for losses on accounts and notes receivable | 256 | -42 |
Deferred income tax expense (benefit) | 883 | -234 |
Changes in operating assets and liabilities: | | |
Accounts and notes receivable | -5,561 | 2,530 |
Merchandise inventories | -3,928 | -3,835 |
Accounts payable | 3,424 | -7,142 |
Net change in other assets and liabilities | -1,046 | -11,951 |
Other, net | 476 | -159 |
Cash provided by operating activities | -107 | -18,975 |
Investing activities: | | |
Additions to property and equipment | -1,067 | -3,263 |
Payments to Acquire Software | 2,490 | 791 |
Additions to property and equipment | | 0 |
Proceeds from the sale of property and equipment | 0 | 94 |
Cash used for investing activities | -3,557 | -3,960 |
Financing activities: | | |
Change in bank overdraft | 1,179 | 20,578 |
Change in intercompany advances | 10,182 | 368 |
Repayment of revolving credit facility | 0 | |
Cash dividends paid | 0 | 0 |
Repurchases of common stock | | 0 |
Excess tax benefits related to share-based compensation | 0 | 0 |
Proceeds from exercise of stock options | 0 | 0 |
Other, net | -747 | -254 |
Cash used for financing activities | 10,614 | 20,692 |
Effect of exchange rate changes on cash and cash equivalents | -4,489 | 245 |
Net increase in cash and cash equivalents | 2,461 | -1,998 |
Cash and cash equivalents at beginning of period | 30,847 | 25,502 |
Cash and cash equivalents at end of period | 33,308 | 23,504 |
Eliminations | | |
Condensed Financial Statements, Captions [Line Items] | | |
Net income (loss) | -23,767 | -27,034 |
Adjustments to reconcile net income to cash provided by (used for) operating activities: | | |
Equity in earnings of subsidiaries | 24,153 | 27,054 |
Depreciation and amortization | 0 | 0 |
Share-based compensation expense | 0 | 0 |
Provision for losses on accounts and notes receivable | 0 | 0 |
Deferred income tax expense (benefit) | 0 | 0 |
Changes in operating assets and liabilities: | | |
Accounts and notes receivable | 6,398 | 419 |
Merchandise inventories | 2,388 | -21 |
Accounts payable | -6,839 | -418 |
Net change in other assets and liabilities | -2,333 | 0 |
Other, net | 0 | |
Cash provided by operating activities | 0 | 0 |
Investing activities: | | |
Additions to property and equipment | 0 | 0 |
Payments to Acquire Software | 0 | 0 |
Additions to property and equipment | | 0 |
Proceeds from the sale of property and equipment | 0 | 0 |
Cash used for investing activities | 0 | 0 |
Financing activities: | | |
Change in bank overdraft | 0 | 0 |
Change in intercompany advances | 0 | 0 |
Repayment of revolving credit facility | 0 | |
Cash dividends paid | 0 | 0 |
Repurchases of common stock | | 0 |
Excess tax benefits related to share-based compensation | 0 | 0 |
Proceeds from exercise of stock options | 0 | 0 |
Other, net | 0 | 0 |
Cash used for financing activities | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
Net increase in cash and cash equivalents | 0 | 0 |
Cash and cash equivalents at beginning of period | 0 | 0 |
Cash and cash equivalents at end of period | $0 | $0 |